COA Instruments Distributed by Mapi Research Trust

default distrib

AAIQOLActivity and Affect Indicators of QOL

Albert Steven M, PhD, MSPH

Therapeutic area: Nervous System Diseases, Mental Disorders
To assess quality of life in dementia

default distrib

ACCEPTChronic Treatment Acceptance Questionnaire

Mapi

Therapeutic area: Generic
The ACCEPT© questionnaire is a generic medication acceptance measure assessing how patients weigh advantages and disadvantages of long-term medications. ACCEPT© may be a predictor of patients' future adherence to and/or persistence with their treatment.

default distrib

ACDAsthma Control Diary

Juniper Elizabeth, MCSP, Msc

Therapeutic area: Respiratory Tract Diseases, Immune System Diseases
To measure the adequacy of clinical asthma control

default distrib

ACQAsthma Control Questionnaire

Juniper Elizabeth, MCSP, Msc

Therapeutic area: Respiratory Tract Diseases, Immune System Diseases
To measure the adequacy of clinical asthma control

default distrib

ACTSAnti-Clot Treatment Scale

Cano Stefan, Lamping Donna L

Therapeutic area: Cardiovascular Diseases, Respiratory Tract Diseases
To measure patient treatment satisfaction with anticoagulation treatment

default distrib

ADCPQAlzheimer’s Disease Caregiver Preference Questionnaire

Novartis Pharmaceuticals Corporation, Mapi

Therapeutic area: Nervous System Diseases, Mental Disorders
To assess caregivers' satisfaction with and preference for patch or capsule treatments in Alzheimer’s Disease patients

default distrib

AdolRQLQAdolescent Rhinoconjunctivitis Quality of Life Questionnaire

Juniper Elizabeth, MCSP, Msc

Therapeutic area: Eye Diseases, Otorhinolaryngologic Diseases, Respiratory Tract Diseases
To measure the functional impairments that are most troublesome to patients between the ages of 12 and 17 years as a result of their rhinoconjunctivitis

default distrib

ADRQLAlzheimer's Disease-Related Quality of Life

Black Betty S, Kasper Judith D, Rabins Peter V

Therapeutic area: Nervous System Diseases, Mental Disorders
To evaluate treatment interventions in Alzheimer's Disease

default distrib

AHLQAdherence to a Healthy Lifestyle questionnaire

Sanofi Aventis

Therapeutic area: Nutritional and Metabolic Diseases, Diagnosis, Pathological Conditions, Signs and Symptoms, Physiological Phenomena
To measure adherence to a healthy lifestyle (diet and exercise; motivation, barriers, results, satisfaction, adherence to lifestyle changes)

default distrib

AIMAscites Impact Measure

Sanofi Aventis

Therapeutic area: Pathological Conditions, Signs and Symptoms
To record patients’ daily experiences of symptoms that trigger a request for a paracentesis in patients with ascites

default distrib

AOM-DiaryAcute Otitis Media Symptoms Diary

Sanofi Aventis

Therapeutic area: Otorhinolaryngologic Diseases
To capture data on the child’s daily level of Acute Otitis Media (AOM) symptom severity and to systematically assess resolution of symptoms

default distrib

AQLQAsthma Quality of Life Questionnaire

Juniper Elizabeth, MCSP, Msc

Therapeutic area: Respiratory Tract Diseases, Immune System Diseases
To measure the functional impairments that are most troublesome to adults (17-70 years) as a result of their asthma

default distrib

ARTSOsteoARthritis Treatment Satisfaction Questionnaire

Pfizer (France), Mapi

Therapeutic area: Musculoskeletal Diseases
To assess patient satisfaction with their osteoarthritis (OA) treatment

default distrib

ASRSAugmentation Severity Rating Scale

The European Restless Legs Syndrome Study Group (EURLSSG)

Therapeutic area: Nervous System Diseases, Mental Disorders
To assess severity of augmentation, the main complication during long-term dopaminergic treatment of restless legs syndrome (RLS)

default distrib

AUQUEIPictured Child’s Quality of Life Self Questionnaire

Dazord Alice, Manificat Sabine

Therapeutic area: Generic
To assess the child’s subjective Quality of Life

default distrib

BAS-GBath Ankylosing Spondylitis Global score

Jones SD, Steiner A, Garrett SL et al.

Therapeutic area: Musculoskeletal Diseases
To reflect the effect of ankylosing spondylitis (AS) on the patient's well-being

default distrib

BASDAIBath Ankylosing Spondylitis Disease Activity Index

Calin Andrei

Therapeutic area: Musculoskeletal Diseases
To define disease activity in patients with ankylosing spondylitis

default distrib

BASFIBath Ankylosing Spondylitis Functional Index

Calin Andrei

Therapeutic area: Musculoskeletal Diseases
To define and monitor functional ability in patients with ankylosing spondylitis

default distrib

BASMIBath Ankylosing Spondylitis Metrology Index

Calin Andrei

Therapeutic area: Musculoskeletal Diseases
To define clinically significant changes in spinal movement

default distrib

BDI-TDIBaseline and Transition Dyspnea Indexes

Mahler Donald A

Therapeutic area: Respiratory Tract Diseases, Immune System Diseases, Digestive System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
To provide a multidimensional measurement of dyspnea based on activities of daily living in symptomatic individuals